Open Access. Powered by Scholars. Published by Universities.®
Other Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Seizures (2)
- Acute kidney injury (1)
- Alternatives (1)
- Arrhythmias (1)
- Bleeding complications (1)
-
- Cannabidiol (1)
- Cardiac failure (1)
- Cardiovascular collapse (1)
- Chronic Pelvic Pain (1)
- Circuit thrombosis (1)
- Deep gray matter (1)
- Disease modifying therapies (1)
- Dravet syndrome (1)
- ECMO (1)
- Epilepsy (1)
- Hemorrhagic stroke (1)
- Hysterectomy (1)
- Imaging (1)
- Incomplete bowel preparation (1)
- Incomplete colonoscopy (1)
- Infection (1)
- Ischemic stroke (1)
- Laparoscopy (1)
- MCID (1)
- MID (1)
- Meniscectomy (1)
- Meniscus (1)
- Multi-organ dysfunction (1)
- Multiple sclerosis (1)
- Neurologic injury (1)
- Publication
- Publication Type
Articles 1 - 6 of 6
Full-Text Articles in Other Analytical, Diagnostic and Therapeutic Techniques and Equipment
A Retrospective Study On The Associations Of Clinical Measures To Mortality In Pediatric Extracorporeal Membrane Oxygenation (Ecmo) Patients, Ammar F. Chauhdri, Ryan Davis Md, Christina Shanti Md, Michelle Veenstra Md, Megan Zacarias, Samantha Carranza, Laura Sansoterra, Nimr Assaf, Christian Hudson-Bradford Md, Elika Ridelman Phd
A Retrospective Study On The Associations Of Clinical Measures To Mortality In Pediatric Extracorporeal Membrane Oxygenation (Ecmo) Patients, Ammar F. Chauhdri, Ryan Davis Md, Christina Shanti Md, Michelle Veenstra Md, Megan Zacarias, Samantha Carranza, Laura Sansoterra, Nimr Assaf, Christian Hudson-Bradford Md, Elika Ridelman Phd
Medical Student Research Symposium
A Retrospective Study on the Associations of Clinical Measures to Mortality in Pediatric Extracorporeal Membrane Oxygenation (ECMO) Patients
Ammar Chauhdri; Ryan Davis, MD; Christina Shanti, MD; Michelle Veenstra, MD; Megan Zacarias; Samantha Carranza; Laura Sansoterra; Nimr Assaf; Christian Hudson-Bradford, MD; Elika Ridelman, PhD
Background: Extracorporeal membrane oxygenation (ECMO) is a form of temporary cardiopulmonary support used in critically ill pediatric patients when conventional therapies fail, yet survival to discharge remains only ~50% nationwide. Prior studies have identified candidate mortality predictors and developed basic risk scores, but these models have limited accuracy and are often derived from registry-level or narrowly defined …
Lack Of Alternatives To Colonoscopy Limits Care Of Patients Unable To Complete Bowel Preparation, Tala Al-Saghir
Lack Of Alternatives To Colonoscopy Limits Care Of Patients Unable To Complete Bowel Preparation, Tala Al-Saghir
Clinical Research in Practice: The Journal of Team Hippocrates
A clinical decision report using:
Benech N, Vinet O, Gaudin JL, et al.: The ONECC Study Group. Colon capsule endoscopy in clinical practice: lessons from a national 5-year observational prospective cohort. Endosc Int Open. 2021;9(10):E1542-E1548. https://doi.org/10.1055/a-1526-09231
for a patient with incomplete bowel preparation and colonoscopy.
The Effect Of Disease Modifying Therapies On Deep Gray Matter: A Longitudinal Comparative Study, Wendy Jin, Evanthia Bernitsas
The Effect Of Disease Modifying Therapies On Deep Gray Matter: A Longitudinal Comparative Study, Wendy Jin, Evanthia Bernitsas
Medical Student Research Symposium
Summary
Cerebral gray matter (GM) atrophy is an important factor in determining disability in Multiple Sclerosis4,9. Disease modifying therapies reduce the GM atrophy to some degree, both in the cortical and deep gray matter (dGM). A previous study has shown that fingolimod (FTY720), asphingosine 1 phosphate immunomodulator can significantly reduced GM and thalamic volume loss in patients with relapsing-remitting Multiple Sclerosis(RRMS)1. In addition to its effect on reducing dGM volume loss, fingolimod is also believed to have protective effect on focal and diffuse dGM damage2,8. The effect of natalizumab on GM atrophy, however, is …
Single Vs. Multiple Laparoscopies: Pain Status One Year Post-Hysterectomy For Chronic Pelvic Pain, Ghadear Shukr, Madeleine R. Gonte, Victoria Webber, David Eisenstein
Single Vs. Multiple Laparoscopies: Pain Status One Year Post-Hysterectomy For Chronic Pelvic Pain, Ghadear Shukr, Madeleine R. Gonte, Victoria Webber, David Eisenstein
Medical Student Research Symposium
Despite the prevalence of chronic pelvic pain (CPP)— affecting one in seven women in the U.S.— its cause is often unknown. As such, an evaluation of our current approaches to the work-up of CPP is warranted. Laparoscopy is considered a gold standard tool in the evaluation of CPP with 40% of all laparoscopies in the U.S. performed for this condition [1]. However, limited data exists portraying the clinical importance and outcomes for repeat diagnostic laparoscopies. This is a retrospective case-control study to determine the incidence of multiple laparoscopies for CPP over the past 10 years, and to compare outcomes between …
: Preoperative Patient-Centric Predictors Of Postoperative Outcomes In Patients Undergoing Arthroscopic Meniscectomy, Sreten Franovic, Noah Kuhlmann, Alexander Pietroski, Collin Schlosser, Luke Hessburg, Kelechi Okoroha, Vasilios Moutzouros, Eric Makhni
: Preoperative Patient-Centric Predictors Of Postoperative Outcomes In Patients Undergoing Arthroscopic Meniscectomy, Sreten Franovic, Noah Kuhlmann, Alexander Pietroski, Collin Schlosser, Luke Hessburg, Kelechi Okoroha, Vasilios Moutzouros, Eric Makhni
Medical Student Research Symposium
The Patient-Reported Outcomes Measurement Information System (PROMIS) is a valid and efficient means of collecting patient outcomes in patients with meniscal tears. The studies purpose was to define the minimally clinical important difference (MCID) for PROMIS domains following meniscectomy procedures. Secondary aims included determining the role of pre-operative PROMIS computer adaptive test (CAT) scores in predicting achievement of MCID following meniscectomy. Patients undergoing arthroscopic meniscectomy who completed PROMIS CAT forms for physical function (PROMIS-PF), pain interference (PROMIS-PI), and depression (PROMIS-D), from July 2017 to July 2019, at a single institution were utilized. MCID was calculated according to the distribution methodology, …
Cannabidiol Is Beneficial In Management Of Drug-Resistant Dravet Syndrome, Nikita Desai
Cannabidiol Is Beneficial In Management Of Drug-Resistant Dravet Syndrome, Nikita Desai
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Devinsky O, Cross H, Laux L, et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017;376(21):2011-2020. doi: 10.1056/NEJMoa1611618.